They clearly had a change of plans. Yes under Ziv'

They clearly had a change of plans. Yes under Ziv's leadership he wanted to start sales immediately, but continuing trials to prove safety is the smarter path to take and actually a very positive and welcomed change in my eyes. We could have been one of a hundred companies to have an undeveloped creme on the market, but sales would have been minuscule compared to a clinically tested and later a fully developed FDA approved product reimbursed by insurance companies. You are underestimating what is happening here and it's not just you. Many fail to understand the monster opportunity here. GW.. share price over 100 dollars because it is close to approval on one drug that will treat a very small number of patients due to the rarity of the disease. Although they have a robust pipeline the share price mainly reflect the one drugs success. Do you believe our product is worth nothing? Do you believe it's 70% effectiveness is not worthy of investment? What about our MM study now fully funded being headed by Dr. Zeevi? What are we chopped liver? The tablet for controlled dosages and the high tech nasal spray are they junk? You are wrong on all fronts. As far as share price goes we can thank JF and Ziv for most of the mess but we will recover slowly but surely.